MetaADEDB 2.0 @ LMMD
Pirinitramide
(IHEHEFLXQFOQJO-UHFFFAOYSA-N)
Structure
SMILES
N#CC(c1ccccc1)(c1ccccc1)CCN1CCC(CC1)(N1CCCCC1)C(=O)N
Type(s)
Approved; Investigational
ATC code(s)
N02AC03
Molecular Formula:
C27H34N4O
Molecular Weight:
430.585
Log P:
4.2683
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
73.36
CAS Number(s):
302-41-0
Synonym(s)
1.
Pirinitramide
2.
Piritramid
3.
Piritramide
4.
Dipidolor
5.
Dipydolor
External Link(s)
MeSHD010892
PubChem Compound9331
ChEBI135699
CHEMBLCHEMBL559288
DrugBankDB12492
DrugCentral3478
KEGGdr:D07288
Therapeutic Target DatabaseD0RX3C
ZINC538198
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisOFFSIDES
2AdenomaOFFSIDES
3Ammonia increasedOFFSIDES
4Anticholinergic SyndromeOFFSIDES
5AtelectasisOFFSIDES
6Bile duct necrosisOFFSIDES
7Biopsy liver abnormalOFFSIDES
8Blood cholinesterase decreasedOFFSIDES
9Blood creatinine increasedOFFSIDES
10Blood glucose fluctuationOFFSIDES
11Blood urea increasedOFFSIDES
12Body TemperatureOFFSIDES
13Bronchoalveolar LavageOFFSIDES
14BronchopneumoniaOFFSIDES
15Candida sepsisOFFSIDES
16Capillary Leak SyndromeOFFSIDES
17Catheter related infectionOFFSIDES
18Chemotherapeutic drug level increasedOFFSIDES
19Choking sensationOFFSIDES
20CholangiolitisOFFSIDES
21CholecystitisOFFSIDES
22Coagulation test abnormalOFFSIDES
23CraniotomyOFFSIDES
24Delusional disorder, persecutory typeOFFSIDES
25DemyelinationOFFSIDES
26Drug withdrawal headacheOFFSIDES
27Eosinophilic myocarditisOFFSIDES
28Erosive gastritisOFFSIDES
29ErythemaOFFSIDES
30Escherichia sepsisOFFSIDES
31General physical health deteriorationOFFSIDES
32HemiparesisOFFSIDES
33Hepatic congestionOFFSIDES
34HepatitisOFFSIDES
35HepatotoxicityOFFSIDES
36Hypotension4429198CTD
37Incision site painOFFSIDES
38Injection site noduleOFFSIDES
39Injury asphyxiationOFFSIDES
40Kidney FailureOFFSIDES
41LacerationOFFSIDES
42LaparotomyOFFSIDES
43LipaseOFFSIDES
44Myoglobin blood increasedOFFSIDES
45Nicotine DependenceOFFSIDES
46OliguriaOFFSIDES
47Pain, Postoperative4429198CTD
48Pancreatic NeoplasmOFFSIDES
49PancreatitisOFFSIDES
50Pericardial effusionOFFSIDES
51PeritonitisOFFSIDES
52PneumothoraxOFFSIDES
53PolyuriaOFFSIDES
54Post procedural complicationOFFSIDES
55Propofol Infusion SyndromeOFFSIDES
56Protein total decreasedOFFSIDES
57Pulmonary congestionOFFSIDES
58Respiratory FailureOFFSIDES
59RhabdomyolysisOFFSIDES
60Septic ShockOFFSIDES
61Soft tissue necrosisOFFSIDES
62Splenic InfarctionOFFSIDES
63Sputum culture positiveOFFSIDES
64Stevens-Johnson SyndromeOFFSIDES
65SubileusOFFSIDES
66TracheobronchitisOFFSIDES
67Troponin I increasedOFFSIDES
68Ureterostomy site discomfortOFFSIDES
69Vanishing bile duct syndromeOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.